Prevalence of Colon Cancer in Elderly Patients with E. faecalis Bacteremia
The prevalence of colorectal cancer in elderly patients with Enterococcus faecalis bacteremia ranges from 0.45% to 14.8%, with the most robust population-based data showing approximately 0.5% at 6 months, though colonoscopy-based studies in selected populations report rates as high as 14.8%.
Evidence from Population-Based Studies
The most methodologically rigorous evidence comes from a 2025 Danish nationwide registry study of 4,664 patients with first-time E. faecalis bloodstream infection (median age 74.9 years). The 6-month cumulative incidence of colorectal cancer was 0.45% (95% CI: 0.28-0.72%), which was 3.7 times higher than age- and sex-matched controls from the general population 1. When including all colorectal neoplasia (cancer plus advanced adenomas), the incidence increased to 2.34% 1.
A 2020 Australian population-based cohort study (median age 71 years) found that among 12 patients with E. faecalis bacteremia who underwent colonoscopy, 75% had previously undiagnosed colorectal neoplasia, though the denominator was small 2. The overall 1-year mortality in this cohort was 40.2%, with colorectal cancer being a significant predictor of mortality (adjusted OR 4.47) 2.
Evidence from Colonoscopy-Based Studies
Studies that systematically performed colonoscopy in E. faecalis bacteremia patients report substantially higher rates, though these represent selected populations:
A 2021 Spanish multicenter study (GAMES cohort) of 142 patients who underwent colonoscopy found colorectal neoplasia in 14.8% (21/142 patients) 3. This study specifically targeted patients with available colonoscopies, introducing selection bias 3.
A 2020 Spanish multicenter study of 78 patients with E. faecalis infective endocarditis who underwent colonoscopy found colorectal disease in 60% (47/78), with 83% of these being neoplastic disease 4. Among patients with unknown source of infection, 64% had gastrointestinal pathology identified 4.
Even among patients with a known source of infection (excluding those with previously diagnosed colorectal disease), 44% had colorectal disease on colonoscopy 4.
Age-Specific Considerations
The elderly population is particularly affected by this association. Nearly 70% of colorectal cancer patients are over 65 years of age, making age the major unchangeable risk factor for sporadic colon cancer 5. The Danish study population had a median age of 74.9 years, directly addressing the elderly demographic in question 1.
The 30-day mortality in elderly patients with E. faecalis bacteremia ranges from 11.7% to 21.4%, with 1-year mortality reaching 40.2%, substantially limiting the window for cancer detection and treatment 2, 6.
Clinical Context and Interpretation
The discrepancy between population-based (0.45%) and colonoscopy-based (14.8%) prevalence estimates reflects:
Selection bias: Colonoscopy studies include patients deemed appropriate candidates for the procedure, excluding those too ill or with limited life expectancy 1.
Detection of precancerous lesions: The higher rates in colonoscopy studies include advanced adenomas, not just invasive cancer 3, 4.
Timing of detection: The Danish study measured 6-month incidence, while colonoscopy studies captured prevalent disease at the time of bacteremia 1.
Comparison to General Population
The absolute 6-month risk of colorectal cancer in elderly patients with E. faecalis bacteremia (0.45%) is approximately 4 times higher than age-matched controls (0.12%) 1. However, the Danish investigators concluded that "the absolute risks do not justify systematic screening for CRC or CRN in patients with E. faecalis BSI" given the low absolute incidence and high competing mortality 1.
Critical Caveats
The 36.3% six-month mortality rate in E. faecalis bacteremia patients substantially limits the benefit of cancer screening, as many patients die from their acute illness or comorbidities before cancer would become clinically significant 1.
Infective endocarditis occurs in 15-25% of community-acquired E. faecalis bacteremia cases, and these patients may have different cancer prevalence than those with other sources 2, 6.
Among patients with E. faecalis infective endocarditis specifically, the rate of colorectal neoplasia approaches 14.8% when colonoscopy is systematically performed, suggesting this subgroup may warrant more aggressive investigation 3.